FDA Approves CITALOPRAM — Aurobindo Pharma Limited

# FDA Approves Generic Citalopram for Aurobindo Pharma Aurobindo Pharma Limited has received FDA approval for its generic citalopram hydrobromide oral formulation (ANDA219985), enabling the Indian drugmaker to enter the competitive antidepressant market and capture share from branded citalopram products. The approval strengthens Aurobindo's portfolio in the high-volume psychiatric medication segment and positions the company to compete on price with existing generic manufacturers.